You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INTR@PID BTC 047

Showing 1 - 25 of 236
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Cervical Cancer Trial in Japan, Spain, United States (M7824, Carboplatin, Paclitaxel)

Completed
  • Cervical Cancer
  • Stanford, California
  • +12 more
Jan 27, 2023

Lung Cancer, Cancer Trial in Rockland, Darmstadt, Madrid (Bintrafusp alfa)

Recruiting
  • Lung Cancer
  • Cancer
  • Bintrafusp alfa
  • Rockland, Massachusetts
  • +2 more
Dec 22, 2021

Tool for Primary Immunodeficiency Disease (PID) in Pakistan

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • Primary Immunodeficiency (PID) Rapid Diagnostic Test (RDT)
  • Karachi, Pakistan
    Aga Khan University Hospital
Feb 24, 2023

Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

Recruiting
  • Iron Deficiency Anemia
  • Adelaide, South Australia, Australia
  • +8 more
Jun 23, 2023

Mother-Child Relations, Substance Use Trial in Surrey, Toronto (Breaking the Cycle Program, Maxxine Wright Program)

Not yet recruiting
  • Mother-Child Relations
  • Substance Use
  • Breaking the Cycle Program
  • Maxxine Wright Program
  • Surrey, British Columbia, Canada
  • +1 more
Mar 3, 2023

Test: A Performance Study With Primary Immunodeficiency Tunisia

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • IgG deficiency rapid screening test
  • Tunis, Tunisia
    National Bone Marrow Transplant center
Nov 10, 2022

Primary Immunodeficiency Trial in Ankara (Inspiratory muscle training, Upper extremity aerobic exercise training, Lower

Not yet recruiting
  • Primary Immunodeficiency
  • Inspiratory muscle training
  • +4 more
  • Ankara, Çankaya, Turkey
    Gazi University, Faculty of Health Sciences, Department of Physi
Oct 14, 2023

Bile cfDNA of Resectable Biliary Tract Carcinomas

Recruiting
  • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
  • Next generation sequencing
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Mar 13, 2023

Observational Monocentric Study on Biliary Tract Cancer (BABEL)

Recruiting
  • Biliary Tract Cancer
    • Roma, Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
    Jul 10, 2023

    Primary Immunodeficiency Disease Trial (Boya IVIG)

    Not yet recruiting
    • Primary Immunodeficiency Disease
    • Boya IVIG
    • (no location specified)
    Nov 21, 2023

    Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)

    Not yet recruiting
    • Biliary Tract Cancer
    • Clayton, Australia
    • +65 more
    Oct 26, 2023

    Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

    Not yet recruiting
    • Biliary Tract Carcinoma
    • Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Apr 10, 2023

    Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • (no location specified)
    Apr 11, 2023

    Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • Changsha, Hunan, China
      Hunan cancer Hospital
    Dec 13, 2022

    Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

    Recruiting
    • Advanced Biliary Tract Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 22, 2023

    Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

    Not yet recruiting
    • Locally Advanced Biliary Tract Cancer
    • Metastatic Biliary Tract Cancer
    • Camrelizumab and Apatinib Plus GP
    • Guangzhou, Guangdong, China
      Cancer center of SunYat-sen University
    Feb 15, 2023

    HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul

    Not yet recruiting
    • HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Feb 19, 2023

    Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

    Not yet recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      SKCCC Johns Hopkins
    Aug 16, 2023

    Biliary Tract Cancer Trial in Boston, Ann Arbor, Nashville (Rucaparib, Nivolumab)

    Active, not recruiting
    • Biliary Tract Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 6, 2022

    Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

    Not yet recruiting
    • Biliary Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Shanghai, China
      Zhongshan hospital, Fudan University
    Aug 12, 2023

    Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,

    Active, not recruiting
    • Biliary Tract Cancer
    • +3 more
    • Leipzig, Germany
    • +6 more
    Jul 1, 2022

    Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

    Recruiting
    • Advanced Biliary Tract Carcinoma
    • Pembrolizumab Injection [Keytruda]
    • Lenvatinib Mesylate
    • Shanghai, Shanghai, China
    • +1 more
    Jul 19, 2022

    Biliary Tract Cancer (BTC) Trial in Taiwan (next-generation sequencing)

    Recruiting
    • Biliary Tract Cancer (BTC)
    • next-generation sequencing
    • Chiayi City, Taiwan
    • +12 more
    Jun 12, 2022